MedPath

Bioburden Reduction of Diabetic Foot Ulcer

Phase 1
Conditions
Diabetic Foot Ulcer
Registration Number
NCT00776854
Lead Sponsor
Nomir Medical Technologies
Brief Summary

Study to see if a laser can get rid of bacateria called MRSA in your diabetic ulcer

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 18 and older
  • Diabetic foot ulcer
  • MRSA positive
Exclusion Criteria

osteomylelitis pregnancy allery to e mycin

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Decrease of Bioburden Effect In diabetic Foot Ulcer28 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nomir Medical

πŸ‡ΊπŸ‡Έ

Waltham, Massachusetts, United States

Nomir Medical
πŸ‡ΊπŸ‡ΈWaltham, Massachusetts, United States
Alan robbins, MD
Contact
781-893-1000

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.